2021 SOR Webinar Series: Evidence-based Treatment for Stimulant Use Disorders

The first webinar of the 2021 SOR webinar series will take place on Thursday, January 21st at 2pm EST! The webinar will focus on evidence-based treatment for stimulant use disorders. Dr. Robert Baillieu, CSAT Medical Officer, and Dr. Neeraj Gandotra, SAMHSA Chief Medical Officer, will be presenting.

There are a limited number of phone lines available for this webinar, so it is encouraged to share lines if possible. Webinar logistical information includes:

Webex Access Information

For Participants:

Conference number: PWXW1912991

Audience passcode: 8800801

Call-In Information

  • Dial-in Number: 888-469-0874; Participant Code: 8800801

https://www.ecfr.gov/current/title-2/subtitle-A/chapter-II/part-200#200.112 Per 2 C.F.R. § 200.112-1113 The Federal awarding agency must establish conflict of interest policies for Federal awards. The non-Federal entity must disclose in writing any potential conflict of interest to the Federal awarding agency or pass-through entity in accordance with applicable Federal awarding agency policy. Failure to adhere to these statues will result in immediate termination of funding.

Virginia’s State Opioid Response (SOR) grant is awarded at the discretion of DBHDS and SAMHSA. All recipients of SOR funding supports evidence-based prevention, treatment and recovery services to address opioid and stimulant misuse and use disorders, including for cocaine and methamphetamine. The SOR grant is not intended to be utilized as a long-term or permanent funding source. All SOR proposals must include a realistic plan for financial sustainability beyond the grant period.